English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 90 Help

  Show only claimed items
Selected(0)Clear Items/Page:    Sort:
Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by reducing K63-specific ubiquitination Journal article
Ding Moyu, Ning Chengqing, Chen Shaoru, Yin Haoran, Xu Jing, WANG YING. Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by reducing K63-specific ubiquitination[J]. doi: 10.1111/bph.17320, 2024, 181(22), 1–18.
Authors:  Ding Moyu;  Ning Chengqing;  Chen Shaoru;  Yin Haoran;  Xu Jing; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:6.8/7.4 | Submit date：2024/10/06
Immunosuppressive Activity  Inflammasome-driven Disease  K63-linked Ubiquitination,  Nlrp3  Triptolide Derivative  Triptolidiol  
Cell Proliferation and Cytotoxicity Assays, The Fundamentals for Drug Discovery Journal article
Niu Jingyi, Li Minai, WANG YING. Cell Proliferation and Cytotoxicity Assays, The Fundamentals for Drug Discovery[J]. https://doi.org/10.53941/ijddp.2024.100013, 2024.
Authors:  Niu Jingyi;  Li Minai;  WANG YING
Favorite |  | Submit date：2024/08/24
Discovery of Natural Product Derivative Triptolidiol as a Direct NLRP3 Inhibitor by Decreasing K63-specific Ubiquitination Presentation
会议地点: Guiyang, China, 会议日期: 2024-07-25 to 2024-07-30, 报告日期: 2024-07-01
Authors:  WANG YING
Favorite |  | Submit date：2024/08/24
Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by decreasing K63-specific ubiquitination Presentation
会议地点: Athens, Greece, 会议日期: 23-06-2024 to 26-06-2024, 报告日期: 2024-06-01
Authors:  WANG YING
Favorite |  | Submit date：2024/08/24
一種中草藥複方及其用途 Patent
专利类型: 发明专利 Invention, 专利号: 42024089859.3, 申请日期: 2024-04,
Authors:  卞兆祥;  WANG YING (王穎);  王一濤
Favorite |  | Submit date：2024/08/29
YIV-906 alleviated Naïve CD4+ T cell transfer-induced murine ulcerative colitis in Rag 1-/- mice Conference paper
Yu Tianyuan, Cheng Yung-Chi, Wang Y(王穎). YIV-906 alleviated Naïve CD4+ T cell transfer-induced murine ulcerative colitis in Rag 1-/- mice[C], 2023.
Authors:  Yu Tianyuan;  Cheng Yung-Chi;  Wang Y(王穎)
Favorite |  | Submit date：2023/08/24
Discovery of triptolidiol as a direct NLRP3 inhibitor by decreasing K63-specific ubiquitination. Conference paper
Ding Moyu, Wang Y(王穎). Discovery of triptolidiol as a direct NLRP3 inhibitor by decreasing K63-specific ubiquitination.[C], 2023.
Authors:  Ding Moyu;  Wang Y(王穎)
Favorite |  | Submit date：2023/08/24
Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by reducing K63-specific ubiquitination Journal article
Ding Moyu, Ning Chengqing, Chen Shaoru, Yin Haoran, Xu jing, WANG YING. Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by reducing K63-specific ubiquitination[J]. British Journal of Pharmacology, 2023.
Authors:  Ding Moyu;  Ning Chengqing;  Chen Shaoru;  Yin Haoran;  Xu jing; et al.
Favorite |   IF:6.8/7.4 | Submit date：2024/08/24
Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor that protect pyroptotic cell death Conference paper
Wang Y(王穎). Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor that protect pyroptotic cell death[C], 2023.
Authors:  Wang Y(王穎)
Microsoft Word | Favorite |  | Submit date：2023/08/24
Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution? Journal article
Deng, Chuanhan, Li, Tianqi, Zhang, Wei, Zhao, Qi, Wang, Ying. Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?[J]. Viruses, 2023, 15(7), 1451.
Authors:  Deng, Chuanhan;  Li, Tianqi;  Zhang, Wei;  Zhao, Qi;  Wang, Ying
Adobe PDF | Favorite | TC[WOS]:11 TC[Scopus]:7  IF:3.8/4.0 | Submit date：2023/06/28
Inflammasome  Viral Infection  Inflammatory Response  Innate Immunity  Host Defense  Therapy